Bruce Jackson
Stock Analyst at Benchmark
(0.98)
# 3,920
Out of 5,140 analysts
124
Total ratings
28.57%
Success rate
-20.9%
Average return
Main Sectors:
Stocks Rated by Bruce Jackson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CV CapsoVision | Maintains: Speculative Buy | $5 → $14 | $6.18 | +126.54% | 2 | Dec 31, 2025 | |
| ABT Abbott Laboratories | Initiates: Buy | $145 | $120.73 | +20.10% | 1 | Oct 10, 2025 | |
| BFRI Biofrontera | Maintains: Buy | $7 → $2.75 | $1.00 | +175.28% | 8 | May 19, 2025 | |
| HUMA Humacyte | Maintains: Buy | $17 → $14 | $0.98 | +1,328.57% | 15 | May 14, 2025 | |
| HBIO Harvard Bioscience | Maintains: Speculative Buy | $4.5 → $3 | $0.59 | +406.41% | 6 | May 13, 2025 | |
| CLNN Clene | Maintains: Buy | $84 → $33 | $5.19 | +535.84% | 8 | May 8, 2025 | |
| GNLX Genelux | Maintains: Speculative Buy | $25 → $23 | $2.83 | +712.72% | 7 | May 8, 2025 | |
| BLTE Belite Bio | Reiterates: Buy | $80 | $159.19 | -49.75% | 9 | Mar 26, 2025 | |
| NEO NeoGenomics | Reiterates: Hold | n/a | $12.69 | - | 8 | Jan 16, 2025 | |
| EXAS Exact Sciences | Reiterates: Buy | $65 | $102.48 | -36.57% | 7 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $0.29 | - | 3 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $30 | $6.60 | +354.55% | 8 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $1.25 | $0.26 | +372.95% | 2 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $3 | $1.05 | +185.71% | 3 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $1.06 | +372.19% | 4 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $300 | $7.13 | +4,107.57% | 2 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $60 | $1.84 | +3,160.87% | 5 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $17 | $0.33 | +5,098.78% | 4 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $24 | $0.94 | +2,450.48% | 3 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $0.46 | +988.14% | 4 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.54 | - | 7 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $20.61 | - | 7 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Speculative Buy | $800 | $3.66 | +21,757.92% | 1 | Aug 8, 2022 |
CapsoVision
Dec 31, 2025
Maintains: Speculative Buy
Price Target: $5 → $14
Current: $6.18
Upside: +126.54%
Abbott Laboratories
Oct 10, 2025
Initiates: Buy
Price Target: $145
Current: $120.73
Upside: +20.10%
Biofrontera
May 19, 2025
Maintains: Buy
Price Target: $7 → $2.75
Current: $1.00
Upside: +175.28%
Humacyte
May 14, 2025
Maintains: Buy
Price Target: $17 → $14
Current: $0.98
Upside: +1,328.57%
Harvard Bioscience
May 13, 2025
Maintains: Speculative Buy
Price Target: $4.5 → $3
Current: $0.59
Upside: +406.41%
Clene
May 8, 2025
Maintains: Buy
Price Target: $84 → $33
Current: $5.19
Upside: +535.84%
Genelux
May 8, 2025
Maintains: Speculative Buy
Price Target: $25 → $23
Current: $2.83
Upside: +712.72%
Belite Bio
Mar 26, 2025
Reiterates: Buy
Price Target: $80
Current: $159.19
Upside: -49.75%
NeoGenomics
Jan 16, 2025
Reiterates: Hold
Price Target: n/a
Current: $12.69
Upside: -
Exact Sciences
Jan 13, 2025
Reiterates: Buy
Price Target: $65
Current: $102.48
Upside: -36.57%
Nov 22, 2024
Reiterates: Hold
Price Target: n/a
Current: $0.29
Upside: -
Nov 22, 2024
Reiterates: Speculative Buy
Price Target: $30
Current: $6.60
Upside: +354.55%
Nov 20, 2024
Reiterates: Speculative Buy
Price Target: $1.25
Current: $0.26
Upside: +372.95%
Oct 11, 2024
Reiterates: Speculative Buy
Price Target: $3
Current: $1.05
Upside: +185.71%
Oct 10, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $1.06
Upside: +372.19%
Sep 4, 2024
Reiterates: Speculative Buy
Price Target: $300
Current: $7.13
Upside: +4,107.57%
Aug 27, 2024
Reiterates: Speculative Buy
Price Target: $60
Current: $1.84
Upside: +3,160.87%
Aug 26, 2024
Reiterates: Speculative Buy
Price Target: $17
Current: $0.33
Upside: +5,098.78%
Aug 14, 2024
Reiterates: Speculative Buy
Price Target: $24
Current: $0.94
Upside: +2,450.48%
Mar 21, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $0.46
Upside: +988.14%
Nov 14, 2023
Downgrades: Hold
Price Target: n/a
Current: $1.54
Upside: -
Sep 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $20.61
Upside: -
Aug 8, 2022
Initiates: Speculative Buy
Price Target: $800
Current: $3.66
Upside: +21,757.92%